Zhejiang Hisun Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Zhejiang Hisun Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 600267.SS.
Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (APIs) and finished drug formulations. The company's extensive therapeutic focus spans oncology, cardiovascular health, infectious diseases, liver support, orthopedics, parasitic...
Can you invest in Zhejiang Hisun Pharmaceutical Co., Ltd.?
Yes. Zhejiang Hisun Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 600267.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zhejiang Hisun Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.